Effect of a treat-to-target intervention of cardiovascular risk factors on subclinical and clinical atherosclerosis in rheumatoid arthritis: a randomised clinical trial.

Benjamin BurggraafDeborah F van Breukelen-van der StoepMarijke A de VriesBoudewijn KlopAnho H LiemGert-Jan M van de GeijnNoelle van der MeulenErwin BirnieEllen M van der ZwanJende van ZebenManuel Castro Cabezas

Published in: Annals of the rheumatic diseases (2019)

NTR3873.

Keyphrases

cardiovascular risk factors
clinical trial
cardiovascular disease
rheumatoid arthritis
open label
double blind
metabolic syndrome
study protocol
randomized controlled trial
phase ii
disease activity
placebo controlled
ankylosing spondylitis
interstitial lung disease
systemic lupus erythematosus
systemic sclerosis